|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 663.37 USD | +2.09% |
|
+2.85% | -15.81% |
| Market Cap | 66.11B 57.9B 53.33B 49.5B 94B 6,306B 95.27B 638B 248B 3,095B 248B 243B 10,732B | P/E 2026 * |
16.8x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 58.24B 51.01B 46.98B 43.61B 82.81B 5,556B 83.94B 562B 219B 2,727B 219B 214B 9,455B | EV / Sales 2026 * |
3.66x | EV / Sales 2027 * | 3.16x |
| Free-Float |
72.33% | Yield 2026 * |
0.6% | Yield 2027 * | 0.68% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +1.93% | ||
| 1 week | +2.85% | ||
| Current month | +4.21% | ||
| 1 month | +2.26% | ||
| 3 months | -14.84% | ||
| 6 months | -16.32% | ||
| Current year | -15.81% |
| 1 week | 623.89 |  | 657.96 |
| 1 month | 594.9 | | 657.96 |
| Current year | 591.52 | | 821.11 |
| 1 year | 537.45 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 31/12/2000 | |
| Chief Executive Officer | 73 | 07/01/1988 | |
| Director of Finance/CFO | 55 | 04/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 31/05/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 31/05/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-30 | Sell | Director | -100 | 0.0001% | ||
| 03-31 | Sell | Director | 100 | 0.0001% | ||
| 03-01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.09% | +2.85% | +18.72% | -7.81% | 66.11B | |
| +0.35% | -2.60% | +50.21% | +225.76% | 55.3B | |
| -1.13% | +40.50% | +40.50% | +40.50% | 42.44B | |
| -0.21% | +8.04% | -50.01% | -53.55% | 41.28B | |
| +0.95% | +17.36% | +168.28% | -30.85% | 32.46B | |
| +1.50% | -3.77% | +56.89% | -26.85% | 30.78B | |
| +1.08% | +0.84% | +68.91% | +83.93% | 23.1B | |
| -3.65% | +9.55% | +5.63% | +188.26% | 20.06B | |
| -0.06% | +3.72% | +67.55% | +135.59% | 17.19B | |
| -1.29% | +7.97% | +76.74% | +357.35% | 15.23B | |
| Average | -0.03% | +5.51% | +50.34% | +91.23% | 34.39B | |
| Weighted average by Cap. | +0.27% | +4.22% | +43.37% | +67.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.9B 13.92B 12.82B 11.9B 22.6B 1,516B 22.91B 153B 59.74B 744B 59.7B 58.39B 2,581B | 17.58B 15.4B 14.18B 13.16B 24.99B 1,677B 25.33B 170B 66.06B 823B 66.01B 64.57B 2,854B |
| Net income | 4.09B 3.58B 3.3B 3.06B 5.81B 390B 5.89B 39.48B 15.36B 191B 15.35B 15.02B 664B | 5.13B 4.5B 4.14B 3.84B 7.3B 490B 7.4B 49.57B 19.29B 240B 19.28B 18.85B 833B |
| Net Debt | -7.87B -6.89B -6.35B -5.89B -11.19B -750B -11.34B -75.97B -29.56B -368B -29.54B -28.9B -1,277B | -10.52B -9.22B -8.49B -7.88B -14.96B -1,004B -15.16B -102B -39.54B -493B -39.52B -38.65B -1,708B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | US$649.81 | -0.68% | 714,338 |
| 02/07/26 | US$654.27 | +4.73% | 1,071,604 |
| 01/07/26 | US$624.72 | +0.19% | 1,170,657 |
| 30/06/26 | US$623.54 | -1.31% | 820,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
